These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7738806)

  • 1. Safety of parenteral hydroxypropyl beta-cyclodextrin.
    Carpenter TO; Gerloczy A; Pitha J
    J Pharm Sci; 1995 Feb; 84(2):222-5. PubMed ID: 7738806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydroxypropylcyclodextrins in parenteral use. II: Effects on transport and disposition of lipids in rabbit and humans.
    Irie T; Fukunaga K; Garwood MK; Carpenter TO; Pitha J; Pitha J
    J Pharm Sci; 1992 Jun; 81(6):524-8. PubMed ID: 1522488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parenteral hydroxypropyl cyclodextrins: intravenous and intracerebral administration of lipophiles.
    Pitha J; Gerloczy A; Olivi A
    J Pharm Sci; 1994 Jun; 83(6):833-7. PubMed ID: 9120816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of 2-hydroxypropyl-beta-cyclodextrin in the assay of acyl-CoA:cholesterol acyltransferase and neutral and acid cholesterol ester hydrolases.
    Liza M; Romero JR; Chico Y; Fresnedo O; Ochoa B
    Lipids; 1996 Mar; 31(3):323-9. PubMed ID: 8900462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety of oral cyclodextrins: effects of hydroxypropyl cyclodextrins, cyclodextrin sulfates and cationic cyclodextrins on steroid balance in rats.
    Gerloczy A; Hoshino T; Pitha J
    J Pharm Sci; 1994 Feb; 83(2):193-6. PubMed ID: 8169787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of cyclodextrins on the disposition of intravenously injected drugs in the rat.
    Frijlink HW; Franssen EJ; Eissens AC; Oosting R; Lerk CF; Meijer DK
    Pharm Res; 1991 Mar; 8(3):380-4. PubMed ID: 2052529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pharmacokinetics of beta-cyclodextrin and hydroxypropyl-beta-cyclodextrin in the rat.
    Frijlink HW; Visser J; Hefting NR; Oosting R; Meijer DK; Lerk CF
    Pharm Res; 1990 Dec; 7(12):1248-52. PubMed ID: 2095562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydroxypropyl-beta-cyclodextrin-mediated efflux of 7-ketocholesterol from macrophage foam cells.
    Kritharides L; Kus M; Brown AJ; Jessup W; Dean RT
    J Biol Chem; 1996 Nov; 271(44):27450-5. PubMed ID: 8910326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of cyclodextrins for manipulating cellular cholesterol content.
    Christian AE; Haynes MP; Phillips MC; Rothblat GH
    J Lipid Res; 1997 Nov; 38(11):2264-72. PubMed ID: 9392424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of parenterally administered cyclodextrins on cholesterol levels in the rat.
    Frijlink HW; Eissens AC; Hefting NR; Poelstra K; Lerk CF; Meijer DK
    Pharm Res; 1991 Jan; 8(1):9-16. PubMed ID: 2014215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of sphingomyelin and phosphatidylcholine degradation on cyclodextrin-mediated cholesterol efflux in cultured fibroblasts.
    Ohvo H; Olsio C; Slotte JP
    Biochim Biophys Acta; 1997 Nov; 1349(2):131-41. PubMed ID: 9421186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydroxypropylcyclodextrins in parenteral use. I: Lipid dissolution and effects on lipid transfers in vitro.
    Irie T; Fukunaga K; Pitha J
    J Pharm Sci; 1992 Jun; 81(6):521-3. PubMed ID: 1522487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complexation of zolpidem with 2-hydroxypropyl-beta-, methyl-beta-, and 2-hydroxypropyl-gamma-cyclodextrin: effect on aqueous solubility, dissolution rate, and ataxic activity in rat.
    Trapani G; Latrofa A; Franco M; Pantaleo MR; Sanna E; Massa F; Tuveri F; Liso G
    J Pharm Sci; 2000 Nov; 89(11):1443-51. PubMed ID: 11015689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative studies of the fate of free and liposome-entrapped hydroxypropyl-beta-cyclodextrin/drug complexes after intravenous injection into rats: implications in drug delivery.
    McCormack B; Gregoriadis G
    Biochim Biophys Acta; 1996 Dec; 1291(3):237-44. PubMed ID: 8980638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe hypervitaminosis A in siblings: evidence of variable tolerance to retinol intake.
    Carpenter TO; Pettifor JM; Russell RM; Pitha J; Mobarhan S; Ossip MS; Wainer S; Anast CS
    J Pediatr; 1987 Oct; 111(4):507-12. PubMed ID: 3655980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydroxypropyl-beta-cyclodextrin can modulate the activity of spinally administered sufentanil.
    Meert TF; Mesens J; Verheyen P; Noorduin H
    Eur J Anaesthesiol; 1992 Sep; 9(5):399-409. PubMed ID: 1396627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of zona binding using 2-hydroxypropyl- beta-cyclodextrin.
    Parinaud J; Vieitez G; Vieu C; Collet X; Perret B
    Hum Reprod; 2000 May; 15(5):1117-20. PubMed ID: 10783363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bile acid and sterol solubilization in 2-hydroxypropyl-beta-cyclodextrin.
    De Caprio J; Yun J; Javitt NB
    J Lipid Res; 1992 Mar; 33(3):441-3. PubMed ID: 1569391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of hydroxypropyl-beta-cyclodextrin in the treatment of aldicarb poisoning in rats.
    Verster RS; Botha CJ
    J S Afr Vet Assoc; 2004 Dec; 75(4):182-5. PubMed ID: 15830603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation, characterization, and anesthetic properties of 2-hydroxypropyl-beta-cyclodextrin complexes of pregnanolone and pregnenolone in rat and mouse.
    Brewster ME; Anderson WR; Loftsson T; Huang MJ; Bodor N; Pop E
    J Pharm Sci; 1995 Oct; 84(10):1154-9. PubMed ID: 8801327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.